(Circulation. 1999;99:1407-1410.)
© 1999 American Heart Association, Inc.
Brief Rapid Communication |
Genome-Wide Linkage Analyses of Systolic Blood Pressure Using Highly Discordant Siblings
From the Institute of Molecular Medicine (J.K., E.B.) and the Human Genetics Center (E.B.), University of Texas–Houston Health Science Center, Houston, Tex; Department of Human Genetics (R.F.), University of Pittsburgh, Pittsburgh, Pa; National Heart, Lung, and Blood Institute (S.C.M.), Bethesda, Md; Division of Hypertension (S.T.T.), Department of Internal Medicine, Mayo Clinic, Rochester, Minn; and Department of Human Genetics (C.F.S.), University of Michigan, Ann Arbor, Mich.
Correspondence to Eric Boerwinkle, PhD, Human Genetics Center, University of Texas–Houston Health Science Center, PO Box 20334, Houston, TX 77225. E-mail eboerwin{at}gsbs.gs.uth.tmc.edu
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background—Elevated blood pressure is a risk factor for cardiovascular, cerebrovascular, and renal diseases. Complex mechanisms of blood pressure regulation pose a challenge to identifying genetic factors that influence interindividual blood pressure variation in the population at large.
Methods and Results—We performed a genome-wide linkage analysis of systolic blood pressure in humans using an efficient, highly discordant, full-sibling design. We identified 4 regions of the human genome that show statistical significant linkage to genes that influence interindividual systolic blood pressure variation (2p22.1 to 2p21, 5q33.3 to 5q34, 6q23.1 to 6q24.1, and 15q25.1 to 15q26.1). These regions contain a number of candidate genes that are involved in physiological mechanisms of blood pressure regulation.
Conclusions—These results provide both novel information about genome regions in humans that influence interindividual blood pressure variation and a basis for identifying the contributing genes. Identification of the functional mutations in these genes may uncover novel mechanisms for blood pressure regulation and suggest new therapies and prevention strategies.
Key Words: hypertension • blood pressure • genetics • genes
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Elevated blood pressure of unknown origin is a common risk factor for cardiovascular disease, stroke, end-stage renal disease, and peripheral vascular disease.1 2 The contributors to elevated blood pressure are poorly understood, but multiple lines of evidence have implicated both genetic and environmental factors.3 Studies aimed at identifying the genes that contribute to interindividual blood pressure variation have been limited to candidate genes; the results have proven informative but not always consistent.4 Investigations of several rare mendelian forms of high blood pressure, such as Liddle syndrome,5 have revealed causative mutations, but their very low frequency diminishes their public health impact. An alternative approach is to use genetic linkage analyses to systematically evaluate the human genome for segments that contain genes that influence blood pressure levels.
Genome-wide genetic linkage studies for complex traits pose several challenges that require careful study design and analysis. Although these traits aggregate in families, they do not segregate in any clear mendelian fashion as a result of there being multiple contributing genes, each with polymorphic allele frequencies and small to moderate effects. In this report, we describe the results of using modern genome-wide linkage analysis methods and an efficient discordant sib pair design6 7 to localize genes that affect interindividual systolic blood pressure (SBP) variation.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
These analyses were performed as part of the GENOA Network of the Family Blood Pressure Program and were based on data collected on 3974 members of 583 multigeneration pedigrees from Rochester, Minn, ascertained without regard to health status.8 SBP levels were measured for each individual 3 times
2 minutes apart with a random-zero sphygmomanometer, and the
average of these 3 readings was used for the linkage analyses
reported herein. Fifty-five pedigrees with 1 or more full siblings
above the sex- and age-specific 80th percentile and 1 or more full
siblings below the sex- and age-specific 20th percentile of the SBP
distribution were identified from the sample of 583 pedigrees. These
pedigrees contained 69 discordant full-sibling pairs. The two
discordant groups of siblings were not significantly different
(P>0.05) for average age (mean, 16 years), weight (mean, 57
kg), height (mean, 162 cm), and body mass index (mean, 21
kg/m2) or for gender prevalence (51% male). All
427 individuals in the 55 pedigrees were genotyped for 359
highly polymorphic marker loci located on the 22 human autosomes
(Research Genetics). Genotyping was performed by standard
methods with an Applied Biosystems/Perkin Elmer 377 automatic
DNA sequencer. Genotypes from all 427 individuals were used to calculate the multipoint identity by descent probabilities every 1 centimorgan (cM) by use of the hidden Markov model method.9 Marker order and genetic distances were provided by the CHLC/Weber screening set versions 8.0 and 6.0 (Research Genetics) and the Marshfield Medical Research Foundation (Marshfield, Wis). Genetic linkage between the marker and trait loci was assessed with the t statistic of Risch and Zhang.7 We compared identity by descent sharing among the 69 discordant sibling pairs with that expected under the null hypothesis of no linkage. Significance levels (probability values) were determined from a 1-sided Student's t test with 68 degrees of freedom. Probability values <0.01 were considered significant, and probability values between 0.01 and 0.05 were considered suggestive. The reader should be cautioned, however, that all results, significant or not, should be confirmed in a similar population before definite conclusions are drawn. Detailed results for each chromosome are not provided in this brief communication. Rather, they may be obtained on the World Wide Web (http://www.circulationaha.org) or by writing the communicating author (E.B.)
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Detailed results of the genome-wide linkage analyses are provided at http://www.circulationaha.org. Multipoint linkage analyses of the 22 autosomes identified 4 regions that showed significant linkage to genes that influence SBP variation (P<0.01) and 8 regions that showed suggestive linkage (0.01<P<0.05). The genomic location of these regions is described in the Table
. The 12
regions are located on 9 chromosomes (chromosomes 2, 5, 6, 9, 15, 16,
18, 20, and 21). The 4 regions of particular interest by virtue of
having probability values <0.01 are located on chromosomes 2, 5, 6,
and 15.
|
The region with the greatest significance level rejecting the
null hypothesis of no linkage between a marker locus and a gene
influencing SBP variation was located on chromosome 6
(P=0.00009; t=-3.96) between markers D6S1009 and
D6S1003 (Figure, panel A). An interval 4
cM in length between positions 143 and 146 cM on chromosome 6 had a
P value of 
0.0001. A 12-cM interval on chromosome 6
between map positions 134 and 155 cM had P values <0.01. On
chromosome 15 at map position 97 cM from the tip of the short arm, the
significance level was 0.0033 (t=-2.80), and the region
between map positions 84 and 101 cM had a level of significance <0.01
(panel B). At the distal end of the long arm of chromosome 5,
the position of marker D5S1471 had a significance level of 0.0076
(t=-2.49) (panel C). Each position between 188 and
192 cM from the beginning of the chromosome 5 linkage map had a
probability value <0.01. On chromosome 2, the position of marker
D2S1788 had a P value of 0.0089 (t=-2.43), and
the map positions between 57 and 59 cM from the beginning of the
chromosome 2 linkage map had a probability value <0.01 (panel
D).
|
1B-adrenergic receptor;
DRD1A, dopamine receptor type 1A. D, Chromosome 2
region. CALM2 indicates calmodulin 2;
NCX1, sodium-calcium exchanger 1. Candidate-gene
locations were obtained from the Genome Database
(http://www.gdbwww.gdb.org) and the National Center for Biotechnology
Information (http://www.ncbi.nlm.nih.gov). |
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
We report herein the results of the first genome-wide linkage analysis for genes that influence interindividual blood pressure variation in humans. This analysis identified several regions that are likely to contribute to genetic differences in SBP levels. Regions 2p22.1 to 2p21, 5q33.3 to 5q34, 6q23.1 to 6q24.1, and 15q25.1 to 15q26.1 on chromosomes 2, 5, 6, and 15, respectively, are significantly linked to genes that influence interindividual SBP differences. These regions contain a number of known genes, shown in the Figure
, the products of which have previously been
suggested to affect blood pressure regulation at the
physiological level. These genes code for proteins
involved in a variety of blood pressure–controlling systems, vascular
smooth muscle tone, natriuresis, cellular calcium homeostasis, and
hormonal and neural regulation of the renin-angiotensin
system. For example, the product of the
aminopeptidase N gene on chromosome 15 regulates
vasopressin release via the mechanism of the N-terminal cleavage of
angiotensin III.10 DNA sequence variants in
these known genes and in nearby anonymous expressed sequence tags are
candidates for contributing to interindividual blood pressure variation
in the population at large by virtue of their positions within the
region identified by linked marker loci. Our analysis also identified regions of the genome and candidate genes that are likely not to have a major impact on interindividual SBP variation in this population. Chromosome 8, for example, provided no evidence that it contains a gene that affect interindividual SBP variation. Each position on this chromosome had a P value between 0.57 and 1.0. As reported previously by other investigators using a candidate-gene approach, the renin gene on chromosome 1 did not yield any evidence for linkage to SBP (P>0.13). Such negative results, however, should be interpreted with caution in light of the low power of genetic exclusion analyses for complex quantitative traits, such as blood pressure.11
We considered a probability value of <0.01 in a region to be statistically significant. This is the same probability value suggested by others (eg, Rao12 ) for identifying regions for further investigation. We realize that this probability value for identification of regions of interest for positional candidate-gene analysis is greater than that suggested by Lander and Kruglyak.13 However, as discussed by many, such extreme probability values overemphasize the statistical interpretation or evaluation of a single study and will promote type II inferential errors (ie, failure to detect a blood pressure–controlling gene when it is really there). In addition, confident identification of linked regions, regardless of probability values, should not come from any single study but rather as the result of confirmation of linkage among similar populations of inference. Ultimately, however, the contributing genes must be identified and functional mutations characterized so that the underlying molecular and physiological mechanisms that relate gene variation to blood pressure variation can be unveiled.
The results of this genome-wide linkage analysis of SBP provide a focus for future genetic studies. First, this study has identified chromosomal regions now hypothesized to contain blood pressure–controlling genes, which requires verification and additional testing. Second, it focuses the search for and cloning of new blood pressure–regulating genes. Finally, it provides a list of genes for detailed DNA sequence analyses aimed at identifying functional mutations that affect SBP variation. Identification of genes that contribute to blood pressure levels will provide a better understanding of the origin of high blood pressure and establish a basis for the development of improved prevention and treatment regimens. The data reported herein on the genetic contributors to interindividual SBP variation have implications not only for our understanding of high blood pressure but also for our understanding of the factors that contribute to its complications, such as cardiovascular, cerebrovascular, and renal diseases.
|
Acknowledgments |
|---|
This study was supported by NIH grants HL-39107, HL-51021, HL-54481, HL-54457, and HL-54464 from the National Heart, Lung, and Blood Institute.
|
Footnotes |
|---|
Guest Editor for this article was Joseph Loscalzo, MD, Boston University Medical Center, Boston, Mass.
Detailed results of the genome-wide linkage analyses discussed in this article can be found on the World Wide Web at http://www.circulationaha.org
Received October 19, 1998; revision received December 22, 1998; accepted January 25, 1999.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
-
MacMahon S, Peto R, Cutler J, Collins R, Sorlie P,
Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure,
stroke, and coronary heart disease, I: prolonged differences in
blood pressure: prospective observational studies corrected for the
regression dilution bias. Lancet. 1990;335:765–774.[Medline]
[Order article via Infotrieve]
-
Whelton PK. Epidemiology of
hypertension. Lancet. 1994;344:101–106.[Medline]
[Order article via Infotrieve]
-
Ward R. Familial aggregation and genetic
epidemiology of hypertension. In: Laragh JH,
Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and
Management. 2nd ed. New York, NY: Raven Press; 1995;1:67–88.
-
Soubrier F. Blood pressure gene at the
angiotensin I-converting enzyme locus: chronicle of a gene
foretold. Circulation. 1998;97:1763–1765.
[Free Full Text]
-
Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams
C, Hansson JH, Schambelan M, Gill JR Jr, Ulick S, Milora RV, Findling
JW, Canessa CM, Rossier BC, Lifton RP. Liddle's syndrome: heritable
human hypertension caused by mutations in the ß subunit of the
epithelial sodium channel. Cell. 1994;79:407–414.[Medline]
[Order article via Infotrieve]
-
Eaves L, Meyer J. Locating human quantitative trait
loci: guidelines for the selection of sibling pairs for genotyping.
Behav Genet. 1994;24:443–455.[Medline]
[Order article via Infotrieve]
-
Risch N, Zhang H. Extreme discordant sib pairs for
mapping quantitative trait loci in humans. Science. 1995;268:1584–1589.
[Abstract/Free Full Text]
-
Turner ST, Weidman WH, Michels VV, Reed TJ, Ormson CL,
Fuller T, Sing CF. Distribution of sodium-lithium countertransport and
blood pressure in Caucasians five to eighty-nine years of age.
Hypertension. 1989;13:378–391.
[Abstract/Free Full Text]
-
Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES.
Parametric and nonparametric linkage
analysis: a unified multipoint approach. Am J Hum
Genet. 1996;58:1347–1363.[Medline]
[Order article via Infotrieve]
-
Zini S, Fournie-Zaluski M-C, Chauvel E, Roques BP,
Corvol P, Llorens-Cortes C. Identification of metabolic
pathways of brain angiotensin II and III using specific
aminopeptidase inhibitors: predominant role
of angiotensin III in the control of vasopressin release.
Proc Natl Acad Sci U S A. 1996;93:11968–11973.
[Abstract/Free Full Text]
-
Page GP, Amos CI, Boerwinkle E. The quantitative LOD
score: test statistic and sample size for exclusion and linkage of
quantitative traits in human sibships. Am J Hum Genet. 1998;62:962–968.[Medline]
[Order article via Infotrieve]
-
Rao DC. CAT scans, PET scans, and genomic scans.
Genet Epidemiol. 1998;15:1–18.[Medline]
[Order article via Infotrieve]
-
Lander E, Kruglyak L. Genetic dissection of complex
traits: guidelines for interpreting and reporting linkage results.
Nat Genet. 1995;11:241–247.[Medline]
[Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  S. D. Nath, V. S. Voruganti, N. H. Arar, F. Thameem, J. C. Lopez-Alvarenga, R. Bauer, J. Blangero, J. W. MacCluer, A. G. Comuzzie, and H. E. Abboud Genome Scan for Determinants of Serum Uric Acid Variability J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3156 - 3163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tomaszewski, F. J. Charchar, M. D. Lynch, S. Padmanabhan, W. Y.S. Wang, W. H. Miller, W. Grzeszczak, C. Maric, E. Zukowska-Szczechowska, and A. F. Dominiczak Fibroblast Growth Factor 1 Gene and Hypertension: From the Quantitative Trait Locus to Positional Analysis Circulation, October 23, 2007; 116(17): 1915 - 1924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Moreno, M. L. Kaldunski, T. Wang, R. J. Roman, A. S. Greene, J. Lazar, H. J. Jacob, and A. W. Cowley Jr. Multiple blood pressure loci on rat chromosome 13 attenuate development of hypertension in the Dahl S hypertensive rat Physiol Genomics, October 19, 2007; 31(2): 228 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Arnett, A. E. Baird, R. A. Barkley, C. T. Basson, E. Boerwinkle, S. K. Ganesh, D. M. Herrington, Y. Hong, C. Jaquish, D. A. McDermott, et al. Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group Circulation, June 5, 2007; 115(22): 2878 - 2901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Pojoga, N. S. Kolatkar, J. S. Williams, T. S. Perlstein, X. Jeunemaitre, N. J. Brown, P. N. Hopkins, B. A. Raby, and G. H. Williams {beta}-2 Adrenergic Receptor Diplotype Defines a Subset of Salt-Sensitive Hypertension Hypertension, November 1, 2006; 48(5): 892 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakayama, N. Kuroi, M. Sano, Y. Tabara, T. Katsuya, T. Ogihara, Y. Makita, A. Hata, M. Yamada, N. Takahashi, et al. Mutation of the Follicle-Stimulating Hormone Receptor Gene 5'-Untranslated Region Associated With Female Hypertension Hypertension, September 1, 2006; 48(3): 512 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Franceschini, J. W. MacCluer, H. H.H. Goring, S. A. Cole, K. M. Rose, L. Almasy, V. Diego, S. Laston, E. T. Lee, B. V. Howard, et al. A Quantitative Trait Loci-Specific Gene-by-Sex Interaction on Systolic Blood Pressure Among American Indians: The Strong Heart Family Study Hypertension, August 1, 2006; 48(2): 266 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gu, S. Su, D. Ge, S. Chen, J. Huang, B. Li, R. Chen, and B. Qiang Association Study With 33 Single-Nucleotide Polymorphisms in 11 Candidate Genes for Hypertension in Chinese Hypertension, June 1, 2006; 47(6): 1147 - 1154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Mullins, M. A. Bailey, and J. J. Mullins Hypertension, Kidney, and Transgenics: A Fresh Perspective Physiol Rev, April 1, 2006; 86(2): 709 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Shmulewitz, S. C. Heath, M. L. Blundell, Z. Han, R. Sharma, J. Salit, S. B. Auerbach, S. Signorini, J. L. Breslow, M. Stoffel, et al. Inaugural Article: Linkage analysis of quantitative traits for obesity, diabetes, hypertension, and dyslipidemia on the island of Kosrae, Federated States of Micronesia. PNAS, March 7, 2006; 103(10): 3502 - 3509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Iwamoto Vascular Na+/Ca2+ exchanger: implications for the pathogenesis and therapy of salt-dependent hypertension Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R536 - R545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Padmanabhan, C. Wallace, P. B. Munroe, R. Dobson, M. Brown, N. Samani, D. Clayton, M. Farrall, J. Webster, M. Lathrop, et al. Chromosome 2p Shows Significant Linkage to Antihypertensive Response in the British Genetics of Hypertension Study Hypertension, March 1, 2006; 47(3): 603 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Bielinski, A. I. Lynch, M. B. Miller, A. Weder, R. Cooper, A. Oberman, Y.-D. I. Chen, S. T. Turner, M. Fornage, M. Province, et al. Genome-Wide Linkage Analysis for Loci Affecting Pulse Pressure: The Family Blood Pressure Program Hypertension, December 1, 2005; 46(6): 1286 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Joe, N. E. Letwin, M. R. Garrett, S. Dhindaw, B. Frank, R. Sultana, K. Verratti, J. P. Rapp, and N. H. Lee Transcriptional profiling with a blood pressure QTL interval-specific oligonucleotide array Physiol Genomics, November 17, 2005; 23(3): 318 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Chen, S. Li, S. R Srinivasan, E. Boerwinkle, and G. S. Berenson Autosomal Genome Scan for Loci Linked to Blood Pressure Levels and Trends Since Childhood: The Bogalusa Heart Study Hypertension, May 1, 2005; 45(5): 954 - 959. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Duggal, A. P. Klein, K. E. Lee, S. K. Iyengar, R. Klein, J. E. Bailey-Wilson, and B. E. K. Klein A Genetic Contribution to Intraocular Pressure: The Beaver Dam Eye Study Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 555 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. de Lange, T. D. Spector, and T. Andrew Genome-Wide Scan for Blood Pressure Suggests Linkage to Chromosome 11, and Replication of Loci on 16, 17, and 22 Hypertension, December 1, 2004; 44(6): 872 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Cai, S. A Cole, R. A Bastarrachea-Sosa, J. W MacCluer, J. Blangero, and A. G Comuzzie Quantitative trait locus determining dietary macronutrient intakes is located on human chromosome 2p22 Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1410 - 1414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Wu, F.-T. Chiang, W. J. Chen, P.-H. Liu, K.-L. Hsu, J.-J. Hwang, L.-P. Lai, J.-L. Lin, C.-D. Tseng, and Y.-Z. Tseng Three single-nucleotide polymorphisms of the angiotensinogen gene and susceptibility to hypertension: single locus genotype vs. haplotype analysis Physiol Genomics, April 13, 2004; 17(2): 79 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Mein, M. J. Caulfield, R. J. Dobson, and P. B. Munroe Genetics of essential hypertension Hum. Mol. Genet., April 1, 2004; 13(90001): R169 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Barkley, A. Chakravarti, R. S. Cooper, R. C. Ellison, S. C. Hunt, M. A. Province, S. T. Turner, A. B. Weder, E. Boerwinkle, and on behalf of the Family Blood Pressure Program Positional Identification of Hypertension Susceptibility Genes on Chromosome 2 Hypertension, February 1, 2004; 43(2): 477 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. F. Loos, P. T. Katzmarzyk, D. C. Rao, T. Rice, A. S. Leon, J. S. Skinner, J. H. Wilmore, T. Rankinen, and C. Bouchard Genome-Wide Linkage Scan for the Metabolic Syndrome in the HERITAGE Family Study J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5935 - 5943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. von Wowern, K. Bengtsson, C. M. Lindgren, M. Orho-Melander, F. Fyhrquist, U. Lindblad, L. Rastam, C. Forsblom, T. Kanninen, P. Almgren, et al. A genome wide scan for early onset primary hypertension in Scandinavians Hum. Mol. Genet., August 15, 2003; 12(16): 2077 - 2081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Morrison, A. Brown, S. L.R. Kardia, S. T. Turner, and E. Boerwinkle Evaluating the Context-Dependent Effect of Family History of Stroke in a Genome Scan for Hypertension Stroke, May 1, 2003; 34(5): 1170 - 1175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Izawa, Y. Yamada, T. Okada, M. Tanaka, H. Hirayama, and M. Yokota Prediction of Genetic Risk for Hypertension Hypertension, May 1, 2003; 41(5): 1035 - 1040. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Cooper, A. Luke, X. Zhu, D. Kan, A. Adeyemo, C. Rorimi, N. Bouzekri, and R. Ward Genome Scan Among Nigerians Linking Blood Pressure to Chromosomes 2, 3, and 19 Hypertension, November 1, 2002; 40(5): 629 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Kotchen, U. Broeckel, C. E. Grim, P. Hamet, H. Jacob, M. L. Kaldunski, J. M. Kotchen, N. J. Schork, P. J. Tonellato, and A. W. Cowley Jr Identification of Hypertension-Related QTLs in African American Sib Pairs Hypertension, November 1, 2002; 40(5): 634 - 639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Khan, E. Singletary, A. Alemayehu, S. Stanislaus, M. P. Printz, T. L. Yaksh, and P. Taylor Nicotinic receptor gene cluster on rat chromosome 8 in nociceptive and blood pressure hyperresponsiveness Physiol Genomics, October 29, 2002; 11(2): 65 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Abe, J. Nakura, M. Yamamoto, J. J. Jin, Z. Wu, Y. Tabara, Y. Yamamoto, M. Igase, K. Kohara, and T. Miki Association of GNAS1 Gene Variant With Hypertension Depending on Smoking Status Hypertension, September 1, 2002; 40(3): 261 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tomaszewski, N. J.R. Brain, F. J. Charchar, W. Y.S. Wang, B. Lacka, S. Padmanabahn, J. S. Clark, N. H. Anderson, H. V. Edwards, E. Zukowska-Szczechowska, et al. Essential Hypertension and {beta}2-Adrenergic Receptor Gene: Linkage and Association Analysis Hypertension, September 1, 2002; 40(3): 286 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Sugiyama, G. A. Churchill, R. Li, L. J. M. Libby, T. Carver, K.-I. Yagami, S. W. M. John, and B. Paigen QTL associated with blood pressure, heart rate, and heart weight in CBA/CaJ and BALB/cJ mice Physiol Genomics, July 12, 2002; 10(1): 5 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Hunt, R. C. Ellison, L. D. Atwood, J. S. Pankow, M. A. Province, and M. F. Leppert Genome Scans for Blood Pressure and Hypertension: The National Heart, Lung, and Blood Institute Family Heart Study Hypertension, July 1, 2002; 40(1): 1 - 6. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Rice, T. Rankinen, Y. C. Chagnon, M. A. Province, L. Perusse, A. S. Leon, J. S. Skinner, J. H. Wilmore, C. Bouchard, and D. C. Rao Genomewide Linkage Scan of Resting Blood Pressure: HERITAGE Family Study Hypertension, June 1, 2002; 39(6): 1037 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kristjansson, A. Manolescu, A. Kristinsson, T. Hardarson, H. Knudsen, S. Ingason, G. Thorleifsson, M. L. Frigge, A. Kong, J. R. Gulcher, et al. Linkage of Essential Hypertension to Chromosome 18q Hypertension, June 1, 2002; 39(6): 1044 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Lange, E. M. Lange, L. F. Bielak, C. D. Langefeld, S. L. Kardia, P. Royston, S. T. Turner, P. F. Sheedy II, E. Boerwinkle, and P. A. Peyser Autosomal Genome-Wide Scan for Coronary Artery Calcification Loci in Sibships at High Risk for Hypertension Arterioscler. Thromb. Vasc. Biol., March 1, 2002; 22(3): 418 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Swynghedauw Susceptibility-conferring polymorphic genotypes in cardiovascular multifactorial syndromes Eur. Heart J., February 2, 2002; 23(4): 271 - 273. [Full Text] [PDF]
|
|
|
|
|
|
P. A. Doris Hypertension Genetics, Single Nucleotide Polymorphisms, and the Common Disease:Common Variant Hypothesis Hypertension, February 1, 2002; 39(2): 323 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Stoll, A. W. Cowley Jr., P. J. Tonellato, A. S. Greene, M. L. Kaldunski, R. J. Roman, P. Dumas, N. J. Schork, Z. Wang, and H. J. Jacob A Genomic-Systems Biology Map for Cardiovascular Function Science, November 23, 2001; 294(5547): 1723 - 1726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Allayee, T. W.A. de Bruin, K. Michelle Dominguez, L. S.-C. Cheng, E. Ipp, R. M. Cantor, K. L. Krass, E. T.P. Keulen, B. E. Aouizerat, A. J. Lusis, et al. Genome Scan for Blood Pressure in Dutch Dyslipidemic Families Reveals Linkage to a Locus on Chromosome 4p Hypertension, October 1, 2001; 38(4): 773 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|